GMED Logo

Globus Medical, Inc. (GMED) 

NYSE$71.04
Market Cap
$11.36B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
605 of 924
Rank in Industry
75 of 118

GMED Insider Trading Activity

GMED Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$35,527,94917100

Related Transactions

Norwalk Leslie Vdirector0$02$620,574$-620,574
Huller KellySVP, GC, Corporate Secretary0$03$1.19M$-1.19M
Pfeil Keith WCOO, CFO0$01$1.25M$-1.25M
RHOADS ANN Ddirector0$02$1.65M$-1.65M
Lemaitre Dandirector0$03$5.31M$-5.31M
Davidar David Ddirector0$05$10.21M$-10.21M
Scavilla Daniel TPresident, CEO0$02$15.85M$-15.85M

About Globus Medical, Inc.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and â€¦

Insider Activity of Globus Medical, Inc.

Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $35.53M worth of Globus Medical, Inc. stock.

On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $99,824 and sold $24.15M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.

List of Insider Buy and Sell Transactions, Globus Medical, Inc.

2025-02-28SaleRHOADS ANN Ddirector
7,500
0.0046%
$78.68$590,100-5.52%
2025-01-10SalePfeil Keith WCOO, CFO
14,167
0.0105%
$88.29$1.25M-2.83%
2024-12-02SaleHuller KellySVP, GC, Corporate Secretary
2,500
0.0019%
$87.00$217,502-0.51%
2024-11-22SaleDavidar David Ddirector
13,512
0.01%
$85.00$1.15M-0.95%
2024-11-22SaleLemaitre Dandirector
1,097
0.0008%
$85.02$93,263-0.95%
2024-11-21SaleDavidar David Ddirector
26,488
0.0195%
$85.00$2.25M-1.15%
2024-11-21SaleScavilla Daniel TPresident, CEO
130,000
0.0957%
$85.00$11.05M-1.15%
2024-11-21SaleLemaitre Dandirector
13,278
0.0098%
$85.00$1.13M-1.15%
2024-11-06SaleScavilla Daniel TPresident, CEO
60,000
0.0431%
$80.02$4.8M+0.91%
2024-11-06SaleHuller KellySVP, GC, Corporate Secretary
5,000
0.0036%
$81.01$405,050+0.91%
2024-10-16SaleDavidar David Ddirector
50,000
0.0393%
$75.04$3.75M+10.76%
2024-10-16SaleHuller KellySVP, GC, Corporate Secretary
7,500
0.0059%
$75.02$562,649+10.76%
2024-09-13SaleDavidar David Ddirector
25,000
0.0187%
$70.46$1.76M+17.68%
2024-09-13SaleRHOADS ANN Ddirector
15,000
0.0112%
$70.36$1.06M+17.68%
2024-07-11SaleNorwalk Leslie Vdirector
1,000
0.0008%
$70.00$70,000+6.11%
2024-05-10SaleLemaitre Dandirector
63,300
0.0468%
$64.61$4.09M+12.53%
2024-05-08SaleDavidar David Ddirector
20,000
0.0156%
$65.00$1.3M+17.86%
2024-03-15SaleNorwalk Leslie Vdirector
10,590
0.0079%
$51.99$550,574+38.56%
2024-03-01SaleHuller KellySVP, GC, Corporate Secretary
7,500
0.0055%
$54.10$405,730+29.73%
2023-05-15SaleLemaitre Dandirector
43,450
0.0436%
$56.98$2.48M-6.08%
Total: 134
*Gray background shows transactions not older than one year

Insider Historical Profitability

25.46%
Douglas Robert Andrewdirector
2005
0.0013%
$142,435.2030+25.46%

GMED Institutional Investors: Active Positions

Increased Positions274+57.2%15M+13.4%
Decreased Positions201-41.96%13M-12.21%
New Positions106New7MNew
Sold Out Positions43Sold Out2MSold Out
Total Postitions552+15.24%110M+1.19%

GMED Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$872,583.009.45%10.86M+240,218+2.26%2024-12-31
Blackrock, Inc.$854,351.009.25%10.64M+363,165+3.54%2024-12-31
Janus Henderson Group Plc$531,302.005.75%6.61M-382,855-5.47%2024-12-31
State Street Corp$288,708.003.13%3.59M+23,743+0.67%2024-12-31
Jpmorgan Chase & Co$225,244.002.44%2.8M+199,556+7.66%2024-12-31
Burgundy Asset Management Ltd.$210,286.002.28%2.62M+43,330+1.68%2024-12-31
Citadel Advisors Llc$206,556.002.24%2.57M+985,036+62.08%2024-12-31
Wellington Management Group Llp$200,527.002.17%2.5M-81,891-3.18%2024-12-31
Sculptor Capital Lp$166,892.001.81%2.08M-132,900-6.01%2024-12-31
Geode Capital Management, Llc$152,384.001.65%1.9M+12,151+0.65%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.